Tomohiko Aihara - Departments of Surgery, Kansai Rosai Hospital

基本信息

浏览量：92

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 105 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Prospective Cohort Study of Abemaciclib-Induced Interstitial Lung Disease in Metastatic Breast Cancer after Chemotherapy

Sayuka Nakayama,Takayuki Iwamoto,Kazuhiro Araki,Kazutaka Narui,Takahiro Nakayama,Hiroyuki Nagase,Naoya Sugimoto,Naruto Taira,Tomohiko Aihara,Yuichiro Kikawa,Hirofumi Mukai

Breast Cancerno. 3 (2025): 607-612

引用0浏览0WOS引用

Real-world Incidence of and Risk Factors for Abemaciclib-Induced Interstitial Lung Disease in Japan: a Nested Case–control Study of Abemaciclib-Induced Interstitial Lung Disease (NOSIDE)

Sayuka Nakayama,Ayuha Yoshizawa,Junji Tsurutani,Kenichi Yoshimura,Gaku Aoki,Takayuki Iwamoto,Hiroyuki Nagase,Naoya Sugimoto,Konomi Kobayashi,Shinyu Izumi,Terufumi Kato,Yasunari Miyazaki,Yasuyuki Kurihara,Naruto Taira,Tomohiko Aihara,Yuichiro Kikawa,Hirofumi Mukai

BREAST CANCERno. 1 (2025): 177-185

引用0浏览0WOS引用

Axillary Surgery in Patients with Breast Cancer with One to Three Positive Micro- or Macrometastases in the Sentinel Lymph Nodes: an Observational Study

Shigeru Imoto,Hiroyuki Yasojima, Takeshi Nagashima, Tatsuya Onishi,Tsutomu Takashima,Masahiro Kitada,Masaya Kawada,Tetsu Hayashida,Yasuto Naoi,Tomohiko Aihara,Noriaki Wada,Hidetaka Kawabata,Masayuki Yoshida,Uhi Toh,Kimiyasu Yoneyama,Akimitsu Yamada,Hitoshi Tsuda,Norikazu Masuda, Mari Saito-Oba,Junichi Sakamoto

Breast cancer (Tokyo, Japan) (2025)

引用0浏览0WOS引用

Eribulin Versus S-1 As First or Second-Line Chemotherapy to Assess Health-Related Quality of Life and Overall Survival in HER2-negative Metastatic Breast Cancer (RESQ Study): a Non-Inferiority, Randomised, Controlled, Open-Label, Phase 3 Trial

Masato Takahashi,Yuichiro Kikawa,Kosuke Kashiwabara,Naruto Taira,Tsuguo Iwatani,Kojiro Shimozuma,Shoichiro Ohtani,Tetsuhiro Yoshinami,Junichiro Watanabe,Masahiro Kashiwaba,Ken-ichi Watanabe,Masahiro Kitada,Koichi Sakaguchi,Yuko Tanabe,Tomohiko Aihara,Hirofumi Mukai

EClinicalMedicine（2024）

引用1浏览0WOS引用

Abstract P1-03-01: Eribulin Versus S-1 As First- or Second- Line Chemotherapy to Assess Health-related Quality of Life and Overall Survival in HER2-negative Metastatic Breast Cancer (RESQ Study): a Non-Inferiority, Randomized Controlled Trial

Yuichiro Kikawa,Kosuke Kashiwabara,Naruto Taira,Tsuguo Iwatani,Kojiro Shimozuma,Shoichiro Ohtani,Tetsuhiro Yoshinami,Junichiro Watanabe,Masahiro Kashiwaba,Ken-ichi Watanabe,Masahiro Kitada,Koichi Sakaguchi,Yuko Tanabe,Tomohiko Aihara,Hirofumi Mukai,Masato Takahashi

Cancer Researchno. 5_Supplement (2023): P1-03

引用0浏览0引用

Anthracycline-containing and Taxane-Containing Chemotherapy for Early-Stage Operable Breast Cancer: a Patient-Level Meta-Analysis of 100 000 Women from 86 Randomised Trials

LANCET（2023）

引用57浏览0WOS引用

Eribulin Versus S1 As First- or Second-Line Chemotherapy to Assess Health-related Quality of Life and Overall Survival in HER2-negative Metastatic Breast Cancer (RESQ Study): a Non-Inferiority, Randomized Controlled Trial

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Yuichiro Kikawa,Yasuhiro Hagiwara,Tomomi Fujisawa,Kazuhiro Araki,Takayuki Iwamoto,Takafumi Sangai,Tadahiko Shien,Shintaro Takao,Reiki Nishimura,Masato Takahashi,Tatsuya Toyama,Tomohiko Aihara,Hirofumi Mukai,Naruto Taira

PLoS ONE（2022）

引用1浏览0WOS引用

Changes in Bone Scan Index and Progression-Free and Overall Survival in Patients with Bone Metastasis of Breast Cancer

Yoichi Naito,Rikiya Nakamura,Naoto Kondo,Yuichiro Kikawa,Hideki Maeda,Hiromitsu Akabane,Yasuaki Sagara,Tomohiko Aihara,Isao Yokota,Hirofumi Mukai

crossref（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn